Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

22. Juli 2010 07:00 ET | Quelle: Auxilium Pharmaceuticals, Inc.

Auxilium Pharmaceuticals to Announce Second Quarter 2010 Results and Conduct Conference Call on Thursday, August 5, 2010

MALVERN, PA--(Marketwire - July 22, 2010) - Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the second quarter 2010 on Thursday,...
21. Juli 2010 16:05 ET | Quelle: Insulet Corporation

Insulet Corporation to Report Second Quarter 2010 Financial Results on Thursday, July 29, 2010

BEDFORD, MA--(Marketwire - July 21, 2010) - Insulet Corporation (NASDAQ: PODD), the leader in tubing-free insulin pump technology with its OmniPod® Insulin Management System, announced...
21. Juli 2010 16:01 ET | Quelle: MELA Sciences

MELA Sciences Announces FDA Needs More Time to Arrange Panel Meeting to Review MelaFind(R) PMA Application

IRVINGTON, NY--(Marketwire - July 21, 2010) - MELA Sciences, Inc. (NASDAQ: MELA) announced today that the U.S. Food and Drug Administration (FDA) has informed the company that it is moving the...
20. Juli 2010 16:01 ET | Quelle: Given Imaging

Given Imaging to Host Second Quarter 2010 Financial Results Conference Calls

YOQNEAM, ISRAEL--(Marketwire - July 20, 2010) - Given Imaging (NASDAQ: GIVN), today announced that the company will host conference calls on Thursday, August 12, 2010 to discuss second quarter 2010...
15. Juli 2010 08:00 ET | Quelle: Nitric BioTherapeutics

Nitric BioTherapeutics Initiates Phase II Onychomycosis Study

BRISTOL, PA--(Marketwire - July 15, 2010) - Nitric BioTherapeutics, Inc. (Nitric Bio) today announced the initiation of a Phase II clinical trial of the company's proprietary drug/device...
12. Juli 2010 07:13 ET | Quelle: Auxilium Pharmaceuticals, Inc.

Auxilium Pharmaceuticals Announces 2Q 2010 XIAFLEX(R) Net Revenues of $3.1 Million

MALVERN, PA--(Marketwire - July 12, 2010) - Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that XIAFLEX® net revenues were $3.1 million for the second quarter 2010,...
09. Juli 2010 16:05 ET | Quelle: Auxilium Pharmaceuticals, Inc.

Auxilium Pharmaceuticals to Host Conference Call to Discuss XIAFLEX(R) Launch and Development Update on July 12, 2010

MALVERN, PA--(Marketwire - July 9, 2010) - Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that Mr. Armando Anido, Chief Executive Officer and President, will provide a XIAFLEX...
01. Juli 2010 08:00 ET | Quelle: Given Imaging

Given Imaging Announces Article in Gastrointestinal Endoscopy Featuring Maneuverable PillCam Capsule

YOQNEAM, ISRAEL--(Marketwire - July 1, 2010) - Given Imaging Ltd (NASDAQ: GIVN), a leader in capsule endoscopy and specialty GI diagnostics, today announced that the first in-human study...
30. Juni 2010 09:55 ET | Quelle: MELA Sciences

MELA Sciences Announces Pricing of Underwritten Public Offering of Common Stock

IRVINGTON, NY--(Marketwire - June 30, 2010) - MELA Sciences, Inc. (NASDAQ: MELA) today announced the pricing of an underwritten public offering of 2,200,000 shares of its common stock at a price...
29. Juni 2010 16:01 ET | Quelle: MELA Sciences

MELA Sciences Announces Proposed Public Offering of Common Stock

IRVINGTON, NY--(Marketwire - June 29, 2010) - MELA Sciences, Inc. (NASDAQ: MELA) today announced its intention to offer, subject to market and other conditions, shares of its common stock in an...

Vorherige Seite